Arterra Bioscience Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	4.17	3.3	3.56	3.83	2.82
Other Revenue	0	0.03	0.03	0.92	1.35
Revenue	4.17	3.34	3.59	4.74	4.17
Revenue Growth (YoY)	25.08%	-7.10%	-24.27%	13.64%	18.96%
Cost of Revenue	1.76	1.49	1.15	1.44	1.26
Gross Profit	2.41	1.85	2.44	3.3	2.91
Selling, General & Admin	1.69	1.56	1.47	1.39	1.28
Amortization of Goodwill & Intangibles	0.03	0.18	0.18	0.19	0.18
Other Operating Expenses	-0.99	-1.3	-1.16	0.18	0.03
Operating Expenses	1.04	0.79	0.84	2.06	1.71
Operating Income	1.37	1.06	1.6	1.25	1.2
Interest Expense	-0	-0.01	-0.01	-0.01	-0.02
Interest & Investment Income	0.33	0.16	0.2	-	-
Earnings From Equity Investments	-	-	-	0	0.01
Other Non Operating Income (Expenses)	0	0.09	0	0.03	0
EBT Excluding Unusual Items	1.7	1.3	1.8	1.27	1.2
Pretax Income	1.7	1.3	1.8	1.27	1.2
Income Tax Expense	0.36	0.23	0.38	0.16	0.09
Net Income	1.34	1.08	1.41	1.11	1.11
Net Income to Common	1.34	1.08	1.41	1.11	1.11
Net Income Growth	24.21%	-23.89%	27.33%	0.18%	29.32%
Shares Outstanding (Basic)	7	7	-	-	-
Shares Outstanding (Diluted)	7	7	-	-	-
EPS (Basic)	0.20	0.16	-	-	-
EPS (Diluted)	0.20	0.16	-	-	-
EPS Growth	24.21%	-	-	-	-
Free Cash Flow	0.42	0.96	1.3	0.86	0.14
Free Cash Flow Per Share	0.06	0.14	-	-	-
Dividend Per Share	0.130	0.100	0.100	0.050	-
Dividend Growth	30.00%	-	100.00%	-	-
Gross Margin	57.85%	55.46%	68.03%	69.69%	69.74%
Operating Margin	32.90%	31.75%	44.57%	26.32%	28.79%
Profit Margin	32.03%	32.26%	39.38%	23.42%	26.57%
Free Cash Flow Margin	10.15%	28.77%	36.23%	18.05%	3.30%
EBITDA	1.71	1.59	2.13	1.74	1.6
EBITDA Margin	41.02%	47.70%	59.38%	36.60%	38.39%
D&A For EBITDA	0.34	0.53	0.53	0.49	0.4
EBIT	1.37	1.06	1.6	1.25	1.2
EBIT Margin	32.90%	31.75%	44.57%	26.32%	28.79%
Effective Tax Rate	21.44%	17.36%	21.33%	12.83%	7.56%
Revenue as Reported	5.27	4.95	5.3	4.61	4.31

Source: S&P Global Market Intelligence. Standard template. Financial Sources.